Nasal Vaccines: Global Markets and Pipeline Analysis

Jan 2023| PHM268A| BCC Publishing
Sample Report

Report Highlights

The global market for nasal vaccines is estimated to increase from $383.8 million in 2022 to reach $568.1 million by 2027, at a compound annual growth rate (CAGR) of 8.2% from 2022 through 2027.

Report Includes

  • 23 data tables and 27 additional tables
  • A comprehensive overview and up-to-date analysis of the global market for nasal vaccines
  • Analyses of the global market trends, with historic market revenue data (sales figures) for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the upcoming market opportunities and trends driving and restricting growth of the global nasal vaccines market and its sub-segments, and the major regions and countries involved in market developments
  • Estimation of the actual market size and revenue forecast for the global nasal vaccines market in USD millions, and its corresponding market share analysis by vaccine type, dosage form, patient group, end-user, and region
  • Discussion of new developments in the nasal vaccines market, underlying clinical trials for all phases and list of vaccines, and their regulatory approvals etc.
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
  • Review of the new announcements, approvals, FDA clearances, partnerships and collaborations in the global nasal vaccines market
  • Detailed company profiles of the leading industry players, including AstraZeneca plc, BioDiem Ltd., BlueWillow Biologics, Meissa Vaccines Inc., and Serum Institute of India Pvt., Ltd.

Report Scope

This report examines trends and sales in the global market for nasal vaccines through 2027. Leaders in the industry and their vaccine portfolios, the need for nasal vaccine development, competitive intelligence and regional trends are discussed. The report includes a PESTEL analysis, that forms in part the base data for qualitative analysis and market estimates.

The report examines all forms of nasal vaccines, such as nasal drops or sprays, but excludes intramuscular and oral vaccines. The report discusses nasal vaccines by type, such as live-attenuated, inactivated, protein subunit and viral vectors. The application areas covered include pediatric and adult. Primary care clinics, hospitals, pharmacies and others are the end-user segments covered.

A $ in front of an amount indicates U.S. dollars unless stated otherwise.

Frequently Asked Questions (FAQs)

The global market for nasal vaccines is estimated at $383.8 million in 2022 and is expected to grow at a CAGR of 8.2% to nearly $568.1 million by 2027.
The key factors driving the growth of nasal vaccines market include increasing incidence of respiratory infections, rising awareness regarding vaccination programs, favorable government support and regulations, and growing investments by leading manufacturers in research and development of nasal vaccines among others.
The nasal vaccines market is segmented based on type, dosage form, application, end-user and region.
Pediatric nasal vaccines segment will dominate the market by the end of 2027.
Key companies in the market includes Bharat Biotech, AstraZeneca, Serum Institute of India, Changchun BCHT Biotechnology Co. (China), Meissa Vaccines, Codagenix, Inc., and CyanVac among others.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $358.0 million
Market size forecast $568.1 million
Growth rate CAGR of 8.2% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered By Vaccine Type, Dosage Form, Patient Group, End User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Rising Incidence of Respiratory Infections
  • Cost-Effective Alternative to Mainstream Vaccines
  • Increased Government Support and Favorable Regulations
  • Rising Awareness of the Need for Vaccination Programs
  • Growing Investments in R&D of Nasal Vaccines
Companies studied
ASTRAZENECA PLC
BHARAT BIOTECH INTERNATIONAL LTD.
BIODIEM LTD.
BLUEWILLOW BIOLOGICS INC.
CODAGENIX INC.
CHANGCHUN BCHT BIOTECHNOLOGY CO.
CYANVAC LLC
INTRAVACC LLC
MEISSA VACCINES INC.
RAZI VACCINE AND SERUM RESEARCH INSTITUTE
SERUM INSTITUTE OF INDIA PVT. LTD.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Nasal Vaccines: Global Markets and Pipeline Analysis78 $5,500 Free
Chapter- 1: Introduction8Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market Overview11$776Free
Chapter- 4: Pipeline Analysis of Nasal Vaccines6$423Free
Chapter- 5: Global Market for Nasal Vaccines by Type4$282Free
Chapter- 6: Global Market for Nasal Vaccines by Dosage Form4$282Free
Chapter- 7: Global Market for Nasal Vaccines by Patient Group4$282Free
Chapter- 8: Global Market for Nasal Vaccines by End User5$353Free
Chapter- 9: Global Market for Nasal Vaccines by Region10$705Free
Chapter- 10: Competitive Landscape5$353Free
Chapter- 11: Company Profiles18$1,269Free
Nasal Vaccines: Global Markets and Pipeline Analysis

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS